Compounded semaglutide: $89 to $299 a month at 13 providers (October 2026)

Key findings

1. Compounded semaglutide: 13 providers publish a calendar-month continuing price, from $89 to $299 a month, with a median of $165. The lowest continuing price is $89 at yourEra. 19 providers publish a comparable price. The other 6 are 1 a prepaid-effective rate, 4 four-week renewals, and 1 a regular price beside a one-month sale, with no calendar-month continuing price, so they are outside this range.
2. Compounded tirzepatide: 13 providers publish a calendar-month continuing price, from $129 to $399 a month, with a median of $299. The lowest continuing price is $129 at yourEra. 18 providers publish a comparable price. The other 5 are 2 prepaid-effective rates, 2 four-week renewals, and 1 a regular price beside a one-month sale, with no calendar-month continuing price, so they are outside this range.
3. Compounded NAD+ injection: 11 providers publish a calendar-month continuing price, from $93 to $249 a month, with a median of $159. The lowest continuing price is $93 at CoreAge Rx. 13 providers publish a comparable price. The other 2 publish four-week renewals and no calendar-month continuing price, so they are outside this range.
4. Compounded Sermorelin injection: 7 providers publish a calendar-month continuing price, from $99 to $199 a month, with a median of $199. The lowest continuing price is $99 at CoreAge Rx. 8 providers publish a comparable price. The other provider publishes a four-week renewal and no calendar-month continuing price, so that provider is outside this range.
5. Compounded oral semaglutide: 7 providers publish a calendar-month continuing price, from $149 to $369 a month, with a median of $249. The lowest continuing price is $149 at PlexusDx.
6. Zepbound: 4 providers publish a calendar-month continuing price, from $299 to $1,399 a month, with a median of $1,234. The lowest recorded continuing rate is Sesame Care at $299 a month, continuing; plus $99/month care.
7. Wegovy: 4 providers publish a calendar-month continuing price, from $349 to $1,695 a month, with a median of $1,522. The lowest recorded continuing rate is Sesame Care at $349 a month after 2 months at $199/month; plus $99/month care.
8. 8 of 79 comparable rows in this index are prepaid-effective rates with no separate continuing monthly price. 27 of 79 comparable rows record a prepaid commitment length. A recorded commitment can sit beside a continuing monthly price. Prepaid-effective rates are not part of the continuing low, median, or high.

Prices by medication

Recorded price changes, newest first

Since 22 August 2026, 106 recorded changes: 27 lower, 12 higher, 66 relabeled, 1 pulled pending re-verification.

Was and Now are Telehealth Ledger's earlier recorded figure and the later recorded figure. The date is the later row's check date, or the commit date when that row has no check date.

Methodology

The continuing price is the calendar-month recurring price. A four-week renewal, an introductory price, a one-month sale, a regular price published beside that sale, a prepaid-effective rate, and an upfront charge are kept separate. A temporary sale price is not the continuing price. When a page publishes a sale price and a regular price, rankings use the regular price and the sale is labeled separately. When a provider tests more than one continuing price, rankings, the median, and this index use the high end. Low and high are the lowest and highest calendar-month continuing prices published for that medication. The median uses each provider's lowest calendar-month continuing price, so a company with two tiers counts once.

Lowest price means the lowest continuing monthly price with medication included, among rows fresh enough to rank. A prepaid-effective rate, an introductory price, and a starting-at floor are labeled separately and are not that lowest price. A row whose check is older than thirty days stays in the table with its real check date. From 21 October 2026 at midnight Eastern, and from then on, a row older than thirty days is left out of lowest and cheapest rankings, sort-first positions, and title claims. Rows already older than thirty days on 19 October 2026 stay rankable until that cutoff.

Every calendar-month continuing price in this index includes the medication.

This is the October 2026 edition. The edition month is the month of the newest price check in the index. This edition stays at its own address. A later price check does not replace a dated edition.

Only providers already published in the catalog are included. Read the methodology for collection, ranking, and publication rules.

Price comparison and publication methodology · Disclosures · CSV · JSON · Summary JSON · Freshness JSON, CC BY 4.0.

Some outbound links generate affiliate commission. Commercial relationships do not control table order, recorded facts, route eligibility, or editorial conclusions.

Questions

What is in the October 2026 Telehealth Price Index?

In the October 2026 Telehealth Price Index, compounded semaglutide calendar-month continuing prices run from $89 to $299 a month at 13 providers, with a median of $165. Prices in this index were checked between 19 October 2026 and 22 October 2026.

Which price is the continuing price?

The continuing price is the calendar-month recurring price. A four-week renewal, an introductory price, a one-month sale, a regular price published beside that sale, a prepaid-effective rate, and an upfront charge are kept separate. A temporary sale price is not the continuing price. When a page publishes a sale price and a regular price, rankings use the regular price and the sale is labeled separately. When a provider tests more than one continuing price, rankings, the median, and this index use the high end. Low and high are the lowest and highest calendar-month continuing prices published for that medication. The median uses each provider's lowest calendar-month continuing price, so a company with two tiers counts once.

Do affiliate relationships change the prices or their order?

Some outbound links generate affiliate commission. Commercial relationships do not control table order, recorded facts, route eligibility, or editorial conclusions.

What the 27 providers we track publish

As of 22 October 2026, this catalog tracks 27 commission-earning GLP-1 providers with a public offer. A provider is counted only when the registry has a sourced value. 23 of 27 publish a price, 19 of 27 publish a calendar-month continuing price, 27 of 27 publish whether medication is included, and 4 of 27 publish a split-pay option.